NovoCure (NVCR) Cash & Current Investments (2014 - 2026)
NovoCure recorded quarterly Cash & Current Investments of $432.0 million in Q1 2026, up 317.84% quarter-over-quarter from $103.4 million in Q4 2025, and down 53.5% year-over-year from $929.1 million in Q1 2025.
NovoCure's Cash & Current Investments history runs 13 years deep, the most recent figure standing at $432.0 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 53.5% year-over-year to $432.0 million; the TTM figure through Mar 2026 stood at $432.0 million (down 53.5% YoY), while the FY2025 annual figure was $103.4 million, down 89.23% from the prior year.
- Cash & Current Investments came in at $432.0 million for Q1 2026 at NovoCure, up from $103.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $969.4 million in Q4 2022 to a low of $103.4 million in Q4 2025.
- A 5-year average of $555.8 million and a median of $432.0 million in 2026 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments jumped 366.22% in 2024 and plunged 89.23% in 2025, its largest moves.
- NovoCure's Cash & Current Investments stood at $969.4 million in 2022, then slipped by 6.07% to $910.6 million in 2023, then increased by 5.41% to $959.9 million in 2024, then slumped by 89.23% to $103.4 million in 2025, then jumped by 317.84% to $432.0 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $432.0 million, $103.4 million, and $344.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 432.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 432.00 Mn |
| Dec 31, 2025 | 103.39 Mn |
| Sep 30, 2025 | 344.64 Mn |
| Jun 30, 2025 | 152.13 Mn |
| Mar 31, 2025 | 929.13 Mn |
| Dec 31, 2024 | 959.87 Mn |
| Sep 30, 2024 | 959.90 Mn |
| Jun 30, 2024 | 168.44 Mn |
| Mar 31, 2024 | 870.15 Mn |
| Dec 31, 2023 | 910.62 Mn |
| Sep 30, 2023 | 921.25 Mn |
| Jun 30, 2023 | 157.49 Mn |
| Mar 31, 2023 | 186.64 Mn |
| Dec 31, 2022 | 969.43 Mn |
| Sep 30, 2022 | 244.04 Mn |
| Jun 30, 2022 | 948.52 Mn |
| Mar 31, 2022 | 191.63 Mn |
| Dec 31, 2021 | 937.70 Mn |
| Sep 30, 2021 | 933.79 Mn |
| Jun 30, 2021 | 360.59 Mn |
| Mar 31, 2021 | 864.40 Mn |
| Dec 31, 2020 | 842.58 Mn |
| Sep 30, 2020 | 235.38 Mn |
| Jun 30, 2020 | 346.71 Mn |
| Mar 31, 2020 | 182.71 Mn |
| Dec 31, 2019 | 179.42 Mn |
| Sep 30, 2019 | 210.17 Mn |
| Jun 30, 2019 | 284.58 Mn |
| Mar 31, 2019 | 256.60 Mn |
| Dec 31, 2018 | 142.76 Mn |
| Sep 30, 2018 | 227.70 Mn |
| Jun 30, 2018 | 218.96 Mn |
| Mar 31, 2018 | 113.76 Mn |
| Dec 31, 2017 | 80.72 Mn |
| Sep 30, 2017 | 186.56 Mn |
| Jun 30, 2017 | 184.38 Mn |
| Mar 31, 2017 | 189.25 Mn |
| Dec 31, 2016 | 219.63 Mn |
| Sep 30, 2016 | 235.55 Mn |
| Jun 30, 2016 | 200.85 Mn |
| Mar 31, 2016 | 235.77 Mn |
| Dec 31, 2015 | 269.42 Mn |
| Sep 30, 2015 | 137.32 Mn |
| Jun 30, 2015 | 106.51 Mn |
| Mar 31, 2015 | 74.22 Mn |
| Dec 31, 2014 | 102.61 Mn |
| Sep 30, 2014 | 79.98 Mn |